Analysis of Plasma Products for Cellular Contaminants: Comparing Standard Preparation Methods-Reference-Cited by-同舟云学术

Analysis of Plasma Products for Cellular Contaminants: Comparing Standard Preparation Methods

Published:2020-04 Issue:4 Volume:230 Page:596-602
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Rieske Richard R.,Kutcher Matthew E.,Audia Jon P.,Carter Kristen T.,Lee Yann-Leei,Tan Yong B.,Gillespie Mark N.,Capley Gina C.,Tatum Danielle M.,Smith Alison A.,Duchesne Juan C.,Simmons Jon D.

Funder

Simmons

NIH

American College of Surgeons

Publisher

Elsevier BV

Subject

Surgery

Reference31 articles.

1. Why implement universal leukoreduction?;Bassuni;Hematol Oncol Stem Cell Ther,2008

2. Biologic effects of leukocytes present in transfused cellular blood products;Bordin;Blood,1994

3. Leukoreduced blood components: Advantages and strategies for its implementation in developing countries;Sharma;Asian J Transfus Sci,2010

4. Plasma transfusion products and contamination with cellular and associated pro-inflammatory debris;Tan;J Am Coll Surg,2019

5. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury;Lee;J Surg Res,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deleterious effects of plasma-derived cellular debris in a porcine model of hemorrhagic shock;Injury;2023-12

2. HemostaticIn VitroProperties of Novel Plasma Supernatants Produced from Late-storage Low-titer Type O Whole Blood;Anesthesiology;2023-04-07

3. Current challenges and best practices for cell-free long RNA biomarker discovery;Biomarker Research;2022-08-18

4. Viable lymphocytes in fresh frozen plasma as a potential source of graft-versus-host disease: risks and solutions;BLOOD TRANSFUS-ITALY;2021

5. Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte cultures;BLOOD TRANSFUS-ITALY;2021